Linnea, Hormos Sign Licensing Agreement

May 23, 2005

1 Min Read
Linnea, Hormos Sign Licensing Agreement

Linnea, Hormos Sign Licensing Agreement

LOCARNO, SwitzerlandLinnea SAsigned a worldwide license agreement with Hormos Medical Corp. making Linnea theexclusive worldwide supplier of Hormos ingredient HMRlignan. The productis a plant lignan isolated and purified from Norway spruce (Piceaabies); it is highly purified to elevate theenterolactone content. Turku, Finland-based Hormos obtained new dietary ingredient (NDI) clearancefrom the U.S. Food and Drug Administration (FDA) in May 2004.

Hormos developed an excellent product in HMRlignan, said MichaelGranville, president of Linnea ( We believe it willgive our customers a significant advantage in price, dosage and bioavailabilitycompared to other sources of lignans.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like